PLR is a readily available and inexpensive biomarker with independent prognostic value in solid tumors.
No takes yet. Share an insight, caveat, or question.
Templeton et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: